Biotechnology company “Qiyu Biotech” was invested by Cointreau Investment and Wosheng Capital with a series A financing worth of tens of millions of yuan

Biotechnology company “Qiyu Biotech” has completed a series A financing of tens of millions of yuan co-invested by Cointreau Investment and Wosheng Capital. This round of financing will mainly be used for preclinical development of major projects.

Qiyu Biotech focuses on the R&D of innovative macromolecular biological drugs, aiming to develop new therapeutic drugs to benefit patients in the fields of refractory cancer and autoimmune diseases in China and the world.